SINGAPORE: A new medication for glaucoma is being tested as an alternative to using daily eye-drops, the most common treatment for the condition, the Singapore Eye Research Institute (SERI) announced on Thursday (Sep 22).
The medication is preloaded in an applicator and injected into the front of the eye.
A slower release of the formula lasts for three to four months, meaning patients can skip daily eye drops.
The new form of glaucoma treatment being demonstrated on Thursday (Sep 22). (Photo: Sara Grosse)
The treatment, which is being trialled in a two-year international study, can be used for most glaucoma patients - except those with closed-angle glaucoma, a less common form of the condition.
In Singapore, the Singapore National Eye Centre started testing the new treatment on patients across public hospitals at the end of last year. Eligible patients receive regular free tests and close monitoring by glaucoma specialists.
Daily eye-drops help relieve the pressure in the eye, but glaucoma experts said patients, especially the elderly, tend to forget or miss their daily medications.
Adherence to eye-drops is estimated to be as low as 40 to 50 per cent among glaucoma patients in Singapore.